Intervacc is trading at SEK 0.97, down 5.57%, amid broader risk-off sentiment.
- Major U.S. indices were down more than 0.5% on September 14, 2026.
- No fresh company-specific announcement was identified on September 14; Intervaccβs latest prominent disclosure was its July 30 EMA application for expanded Strangvac immunity.
- The next interim report is scheduled for November 12; the decline appears more consistent with global market pressure than a confirmed company catalyst.